Search research articles
Contact Us
Filters
Showing results (201-210 of 234) with videos related to
Page
of 24
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 15, 2007
Cigarette smoking and irinotecan treatment: pharmacokinetic interaction and effects on neutropenia
Jessica M van der Bol, Ron H J Mathijssen, Walter J Loos, et al.
Molecular Cancer Therapeutics
|
June 11, 2009
Phase I safety, pharmacokinetic, and pharmacogenomic trial of ES-285, a novel marine cytotoxic agent, administered to adult patients with advanced solid tumors
Richard D Baird, Jos Kitzen, Paul A Clarke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 6, 2005
Phase I and pharmacologic study of PKI166, an epidermal growth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignancies
Ronald Hoekstra, Herlinde Dumez, Ferry A L M Eskens, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 31, 2010
Early cessation of the clinical development of LiPlaCis, a liposomal cisplatin formulation
Maja J A de Jonge, Marije Slingerland, Walter J Loos, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 2, 2014
Towards new methods for the determination of dose limiting toxicities and the assessment of the recommended dose for further studies of molecularly targeted agents--dose-Limiting Toxicity and Toxicity Assessment Recommendation Group for Early Trials of Targeted therapies, an European Organisation for Research and Treatment of Cancer-led study
Sophie Postel-Vinay, Laurence Collette, Xavier Paoletti, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 25, 2024
Empowering effective biomarker-driven precision oncology: A call to action
Mark Lawler, Peter Keeling, Olga Kholmanskikh, et al.
Clinical Pharmacology and Therapeutics
|
August 8, 2006
Association of enzyme and transporter genotypes with the pharmacokinetics of imatinib
Erin R Gardner, Herman Burger, Ron H van Schaik, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 30, 2005
Phase I safety, pharmacokinetic, and pharmacodynamic study of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 in patients with advanced cancer
Ronald Hoekstra, Filip Y F L de Vos, Ferry A L M Eskens, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 2, 2012
A long-term prospective population pharmacokinetic study on imatinib plasma concentrations in GIST patients
Karel Eechoute, Martin N Fransson, An K Reyners, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 6, 2006
A phase I study of a new nucleoside analogue, OSI-7836, using two administration schedules in patients with advanced solid malignancies
Chooi P Lee, Maja J A de Jonge, Anne E O'Donnell, et al.
Page
of 24
Search research articles
Search
Showing results (201-210 of 234) with videos related to
Sort By:
Page
of 24
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 15, 2007
Cigarette smoking and irinotecan treatment: pharmacokinetic interaction and effects on neutropenia
Jessica M van der Bol, Ron H J Mathijssen, Walter J Loos, et al.
Molecular Cancer Therapeutics
|
June 11, 2009
Phase I safety, pharmacokinetic, and pharmacogenomic trial of ES-285, a novel marine cytotoxic agent, administered to adult patients with advanced solid tumors
Richard D Baird, Jos Kitzen, Paul A Clarke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 6, 2005
Phase I and pharmacologic study of PKI166, an epidermal growth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignancies
Ronald Hoekstra, Herlinde Dumez, Ferry A L M Eskens, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 31, 2010
Early cessation of the clinical development of LiPlaCis, a liposomal cisplatin formulation
Maja J A de Jonge, Marije Slingerland, Walter J Loos, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 2, 2014
Towards new methods for the determination of dose limiting toxicities and the assessment of the recommended dose for further studies of molecularly targeted agents--dose-Limiting Toxicity and Toxicity Assessment Recommendation Group for Early Trials of Targeted therapies, an European Organisation for Research and Treatment of Cancer-led study
Sophie Postel-Vinay, Laurence Collette, Xavier Paoletti, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 25, 2024
Empowering effective biomarker-driven precision oncology: A call to action
Mark Lawler, Peter Keeling, Olga Kholmanskikh, et al.
Clinical Pharmacology and Therapeutics
|
August 8, 2006
Association of enzyme and transporter genotypes with the pharmacokinetics of imatinib
Erin R Gardner, Herman Burger, Ron H van Schaik, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 30, 2005
Phase I safety, pharmacokinetic, and pharmacodynamic study of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 in patients with advanced cancer
Ronald Hoekstra, Filip Y F L de Vos, Ferry A L M Eskens, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 2, 2012
A long-term prospective population pharmacokinetic study on imatinib plasma concentrations in GIST patients
Karel Eechoute, Martin N Fransson, An K Reyners, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 6, 2006
A phase I study of a new nucleoside analogue, OSI-7836, using two administration schedules in patients with advanced solid malignancies
Chooi P Lee, Maja J A de Jonge, Anne E O'Donnell, et al.
Page
of 24